India's advanced digestive healthcare is growing with exclusive gastroenterology hospitals focusing on complex disorders.
The latest research on Myriad Genetics trims the modeled fair value only slightly, from US$8.32 to US$8.12 per share, and aligns a new US$7 price target with expectations across the broader ...
Rutgers Develops New Tool for Examining Cancer Genomic Data that Could Improve Treatment When scientists sequence tumor DNA, ...
The banking credit system stands alongside businesses investing in the Single SEZ for the Mezzogiorno. The memorandum of ...
In this podcast series, Alex Shandrovsky interviews investors about benchmarks for funding Alt Proteins in 2026 and uncovers the investment playbooks of ...
Entering 2026, the electronics supply chain is defined by strong demand, shifting trade policies, and ongoing geopolitical ...
Entering 2026, the electronics supply chain is defined by strong demand, shifting trade policies, and ongoing geopolitical uncertainty. Customers increasingly seek supply assurance and smarter ...
Renova Hospitals launches RIOS – Renova Institute of Onco Sciences to deliver coordinated, patient-centered multidisciplinary cancer care ...
The combination of GENEROUS for Medicaid, Globe for Medicare Part B and Guard for Medicare Part D will heavily impact the US drug market. President Trump’s rhetoric has been that other countries ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results